Related Experiment Videos
Contaminated medicaments in use in a hospital for diseases of the skin
The Journal of Hygiene
|February 1, 1980
Abstract:
Topical medicaments used by patients with diseases of the skin were examined for microbial contamination. Ps. aeruginosa was isolated from stock pots of a diluted emulsifying ointment used as a soap substitute in the bath. Cross-contamination between patients and medicament was subsequently shown to have occurred.
Insights
Microbial contamination of topical skin medicaments is a concern. Pseudomonas aeruginosa was found in an emulsifying ointment, indicating cross-contamination between patients and the medication.
Area of Science:
- Dermatology
- Microbiology
- Pharmaceutical Science
Background:
- Topical medicaments are widely used for skin diseases.
- The potential for microbial contamination in these preparations is a significant concern for patient safety.
- Emulsifying ointments are common vehicles for topical therapies and can be used as soap substitutes.
Purpose of the Study:
- To investigate microbial contamination in topical medicaments used by dermatology patients.
- To identify specific microorganisms present in commonly used topical preparations.
- To determine the potential for cross-contamination in the use of these medicaments.
Main Methods:
- Samples of topical medicaments, specifically a diluted emulsifying ointment, were collected.
- Microbial analysis was performed to isolate and identify contaminating organisms.
- The study investigated the potential routes of contamination, including patient-to-medicament transfer.
Main Results:
- Pseudomonas aeruginosa, a common opportunistic pathogen, was isolated from stock pots of the diluted emulsifying ointment.
- The emulsifying ointment was used as a soap substitute, increasing the risk of contamination.
- Evidence of cross-contamination between patients and the medicament was established.
Conclusions:
- Diluted emulsifying ointments used as soap substitutes can become contaminated with bacteria like Pseudomonas aeruginosa.
- Patient use of topical medicaments poses a risk of cross-contamination, potentially leading to infection transmission.
- Strict hygiene practices and formulation considerations are crucial to prevent microbial contamination in topical dermatological preparations.